These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 32463388)
1. Prognostic role of positron emission tomography and computed tomography parameters in stage I lung adenocarcinoma. Carretta A; Bandiera A; Muriana P; Viscardi S; Ciriaco P; Gajate AMS; Arrigoni G; Lazzari C; Gregorc V; Negri G Radiol Oncol; 2020 May; 54(3):278-284. PubMed ID: 32463388 [TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of nomogram based on whole tumour size, tumour disappearance ratio on CT and SUVmax on PET in lung adenocarcinoma. Song SH; Ahn JH; Lee HY; Lee G; Choi JY; Kang J; Kim EY; Han J; Kwon OJ; Lee KS; Kim HK; Choi YS; Kim J; Shim YM Eur Radiol; 2016 Jun; 26(6):1538-46. PubMed ID: 26455720 [TBL] [Abstract][Full Text] [Related]
3. New positron emission tomography derived parameters as predictive factors for recurrence in resected stage I non-small cell lung cancer. Melloni G; Gajate AM; Sestini S; Gallivanone F; Bandiera A; Landoni C; Muriana P; Gianolli L; Zannini P Eur J Surg Oncol; 2013 Nov; 39(11):1254-61. PubMed ID: 23948705 [TBL] [Abstract][Full Text] [Related]
4. Volumetric PET parameters can predict overall survival in advanced lung adenocarcinoma. Yanarateş A; Yazici B Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):3-8. PubMed ID: 31818695 [TBL] [Abstract][Full Text] [Related]
5. Role of PET/CT in Management of Early Lung Adenocarcinoma. Shao X; Niu R; Jiang Z; Shao X; Wang Y AJR Am J Roentgenol; 2020 Feb; 214(2):437-445. PubMed ID: 31714848 [No Abstract] [Full Text] [Related]
6. Use of a prognostic risk score that aggregates the FDG-PET/CT SUVmax, tumor size, and histologic group for predicting the prognosis of pStage I lung adenocarcinoma. Kawakita N; Toba H; Kawakami Y; Takizawa H; Bando Y; Otuska H; Matsumoto D; Takashima M; Tsuboi M; Yoshida M; Kondo K; Tangoku A Int J Clin Oncol; 2020 Jun; 25(6):1079-1089. PubMed ID: 32130543 [TBL] [Abstract][Full Text] [Related]
7. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters. Takahashi M; Shigematsu Y; Ohta M; Tokumasu H; Matsukura T; Hirai T J Thorac Cardiovasc Surg; 2014 Jan; 147(1):54-9. PubMed ID: 24131786 [TBL] [Abstract][Full Text] [Related]
8. [The correlation between metabolic parameters in (18)F-FDG PET-CT and solid and micropapillary histological subtypes in lung adenocarcinoma]. Guo Y; Yao ZM; Chen M; Chen CX Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):555-561. PubMed ID: 35754230 [No Abstract] [Full Text] [Related]
9. Tumour standardized uptake value on positron emission tomography is a novel predictor of adenocarcinoma in situ for c-Stage IA lung cancer patients with a part-solid nodule on thin-section computed tomography scan. Hattori A; Suzuki K; Matsunaga T; Fukui M; Tsushima Y; Takamochi K; Oh S Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):329-34. PubMed ID: 24351509 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of metabolic variables of [18F]FDG PET/CT in surgically resected stage I lung adenocarcinoma. Wang XY; Zhao YF; Liu Y; Yang YK; Wu N Medicine (Baltimore); 2017 Sep; 96(35):e7941. PubMed ID: 28858121 [TBL] [Abstract][Full Text] [Related]
11. The value of preoperative positron emission tomography/computed tomography in differentiating the invasive degree of hypometabolic lung adenocarcinoma. Su Y; Zhou H; Huang W; Li L; Wang J BMC Med Imaging; 2023 Feb; 23(1):31. PubMed ID: 36765284 [TBL] [Abstract][Full Text] [Related]
12. [Value of PET/CT Combined with CT Three-dimensional Reconstruction in Distinguishing Different Pathological Subtypes of Early Lung Adenocarcinoma]. You J; Zhang G; Gao X; Chen Y; Shu Y Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):468-474. PubMed ID: 34120430 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of FDG PET/CT derived parameters in prediction of histopathological finding during the surgery in patients with pancreatic adenocarcinoma. Myssayev A; Myssayev A; Ideguchi R; Eguchi S; Adachi T; Sumida Y; Tobinaga S; Uetani M; Kudo T PLoS One; 2019; 14(1):e0210178. PubMed ID: 30629646 [TBL] [Abstract][Full Text] [Related]
15. Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma. Zhou J; Li Y; Zhang Y; Liu G; Tan H; Hu Y; Xiao J; Shi H Oncotarget; 2017 Apr; 8(14):23312-23321. PubMed ID: 28423576 [TBL] [Abstract][Full Text] [Related]
16. Koh YW; Lee SJ; Park SY Ann Nucl Med; 2019 Feb; 33(2):93-102. PubMed ID: 30324426 [TBL] [Abstract][Full Text] [Related]
17. Utility of Maximum Standard Uptake Value as a Predictor for Differentiating the Invasiveness of T1 Stage Pulmonary Adenocarcinoma. Fu L; Alam MS; Ren Y; Guan W; Wu H; Wang Q; Han Y; Zhou W; Li H; Wang Z Clin Lung Cancer; 2018 May; 19(3):221-229. PubMed ID: 29275041 [TBL] [Abstract][Full Text] [Related]
18. Relationship between Bu L; Tu N; Wang K; Zhou Y; Xie X; Han X; Lin H; Feng H Korean J Radiol; 2022 Jan; 23(1):112-123. PubMed ID: 34983098 [TBL] [Abstract][Full Text] [Related]
19. Maximum Standardized Uptake Value on Positron Emission Tomography is Associated With More Advanced Disease and High-risk Features in Lung Adenocarcinoma. Koike T; Sato N; Hosoda Y; Tazawa M; Goto T; Sato S; Yamazaki M; Toyabe SI; Tsuchida M Semin Thorac Cardiovasc Surg; 2022; 34(3):1051-1060. PubMed ID: 34320398 [No Abstract] [Full Text] [Related]
20. Predictive accuracy of lepidic growth subtypes in early-stage adenocarcinoma of the lung by quantitative CT histogram and FDG-PET. Eriguchi D; Shimada Y; Imai K; Furumoto H; Okano T; Masuno R; Matsubayashi J; Kajiwara N; Ohira T; Ikeda N Lung Cancer; 2018 Nov; 125():14-21. PubMed ID: 30429012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]